focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.78
Bid: 42.66
Ask: 42.76
Change: -0.38 (-0.88%)
Spread: 0.10 (0.234%)
Open: 42.16
High: 43.04
Low: 42.16
Prev. Close: 43.16
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Interim CEO and director

3 Oct 2016 07:00

RNS Number : 4489L
Assura PLC
03 October 2016
 

Assura plc 

 

Appointment of Jonathan Murphy as Interim CEO and Andrew Darke as Property Director to the Board

 

The search process to appoint a new Chief Executive Officer for Assura is ongoing. While the process continues, Jonathan Murphy, currently the Finance Director, has been appointed Interim CEO to lead the business through this time as well as continuing with his responsibilities as Finance Director. Andrew Darke, Property Director, has also been appointed to the board, retaining responsibility for the property operations and developments. Simon Laffin, who has been Executive Chairman since March, will revert to his non-executive role.

 

Simon Laffin commented:

 

"We are focused on appointing the right person as CEO. I am delighted that Jonathan Murphy has agreed to take on the role on an interim basis and that Andrew Darke is joining the board. These appointments reflect the great work that they have both done over this transitional period."

 

Jonathan Murphy said:

 

"Assura continues to trade well with further strong growth as shown by today's trading update. I look forward to working with Andrew Darke on the board to ensure our continued success."

 

There is no information required to be disclosed pursuant to Listing Rule 9.6.13R in respect of Andrew Darke.

 

 

 - Ends-

 

For more information, please contact:

 

 

Assura plc

 

Tel: 01925 420660

Simon Laffin

Jonathan Murphy

 

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

 

Notes to Editors

 

On 4 March this year, Assura announced that Simon Laffin was becoming Executive Chairman to cover the absence of Graham Roberts, the CEO. This was further updated on 14 June, when it was announced that Graham was stepping down as CEO, and that Simon would remain as Executive Chairman whilst a process to appoint a new CEO was in process. On 4 July, the company announced that Graham had sadly passed away. 

 

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington,

works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2016, Assura's property portfolio was valued at £1,111million.

 

 Further information is available at www.assuraplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAFEFEEPKFAF
Date   Source Headline
1st Feb 20167:00 amRNSTotal Voting Rights
29th Jan 20162:00 pmRNSNotification of Vesting of Share Award to PDMR
22nd Jan 20167:00 amRNSAcquisition and Issue of Consideration Shares
19th Jan 20162:12 pmRNSScrip Dividend Declaration
6th Jan 20167:00 amRNSDirector/PDMR Shareholding
24th Dec 20157:00 amRNSScrip Calculation Price
22nd Dec 20155:06 pmRNSDirector/PDMR Shareholding
9th Dec 20157:00 amRNSNotice of Dividend & Introduction of Scrip Scheme
19th Nov 20157:00 amRNSInterim Results 2015
12th Nov 20157:00 amRNSDebt Redemption
2nd Nov 201512:14 pmRNSAcquisition and Issue of Consideration Shares
15th Oct 20151:53 pmRNSNotification of Major Interest in Shares
14th Oct 20155:10 pmRNSDirector/PDMR Shareholdings
13th Oct 201511:58 amRNSConfirmation of Quarterly Interim Dividend
12th Oct 20152:27 pmRNSResult of General Meeting
12th Oct 20157:00 amRNSResult of Proposed Share Issue
1st Oct 20159:59 amRNSTotal Voting Rights
28th Sep 20155:49 pmRNSPDMR Sale of Shares under VCP
25th Sep 20155:50 pmRNSAward and Exercise of Nil Cost Options under VCP
24th Sep 20154:53 pmRNSPublication of Prospectus
24th Sep 20157:00 amRNSProposed Share Issue and Notice of GM
8th Sep 20155:41 pmRNSTR1 Notification of Major Interest in Shares
13th Aug 201511:02 amRNSAnnual Information Update
21st Jul 20155:44 pmRNSResult of AGM
21st Jul 20154:00 pmRNSAcquisition and Issue of Consideration Shares
21st Jul 20157:00 amRNSTrading Update
18th Jun 20157:00 amRNSConfirmation of Quarterly Interim Dividend
17th Jun 20152:53 pmRNSCompany Secretary Appointment
2nd Jun 201512:58 pmRNSNotification of Major Interest In Shares
21st May 20157:00 amRNSFull Year Results
7th May 201512:10 pmRNSNotification of Major Interest in Shares
1st May 20153:28 pmRNSNotice of Results
15th Apr 20154:11 pmRNSNotification of Major Interest in Shares
14th Apr 20155:39 pmRNSNotification of Major Interest in Shares
2nd Apr 20155:09 pmRNSConfirmation of Quarterly Interim Dividend
26th Mar 201511:16 amRNSDirector/PDMR Shareholding
6th Mar 20158:50 amRNSEPRA Index Inclusion
4th Feb 20157:00 amRNSTrading Update
30th Jan 20159:42 amRNSNotification of Major Interest in Shares
29th Jan 20153:56 pmRNSNotification of Vesting of Share Award to PDMR
28th Jan 20158:21 amRNSAdmission of Assura plc shares
27th Jan 20151:53 pmRNSCourt hearing approves new corporate structure
23rd Jan 20152:27 pmRNSPublication of Prospectus
23rd Jan 201511:08 amRNSTR-1: Notification of Major Interest in Shares
14th Jan 201512:42 pmRNSResults of Shareholder Meetings
12th Jan 20157:00 amRNSForward funding and acquisition update
7th Jan 20157:00 amRNSAssura completes Sudbury Community Health Centre
17th Dec 20145:27 pmRNSPosting of Shareholder Circular & Meeting Notices
17th Dec 201410:16 amRNSAcquisition of a medical centre for £10.1 million
16th Dec 201412:12 pmRNSNew Corporate Structure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.